B. Riley Financial Has Lowered Expectations for Joint (NASDAQ:JYNT) Stock Price

Joint (NASDAQ:JYNT) had its price objective reduced by investment analysts at B. Riley Financial from $9.00 to $8.00 in a research report issued on Monday, Benzinga reports. The firm currently has a “neutral” rating on the stock. B. Riley Financial‘s price objective would indicate a potential upside of 20.52% from the stock’s previous close.

A number of other brokerages have also commented on JYNT. Weiss Ratings lowered Joint from a “sell (d+)” rating to a “sell (d)” rating in a research report on Monday, October 26th. Wall Street Zen downgraded Joint from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Two equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Joint presently has a consensus rating of “Reduce” and a consensus price target of $8.00.

Joint Price Performance

JYNT opened at $6.64 on Monday. Joint has a one year low of $6.60 and a one year high of $10.67. The company’s 50 day simple moving average is $7.66 and its 200-day simple moving average is $8.53. The stock has a market capitalization of $93.86 million, a P/E ratio of 33.05 and a beta of 1.16.

Joint (NASDAQ:JYNT) last issued its quarterly earnings results on Thursday, November 5th. The company reported $0.10 earnings per share for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Joint had a net margin of 4.81% and a return on equity of 22.11%. The business had revenue of $13.55 million during the quarter, compared to analyst estimates of $14.85 million. As a group, analysts anticipate that Joint will post 0.31 EPS for the current year.

Institutional Investors Weigh In On Joint

Several institutional investors have recently modified their holdings of JYNT. R Squared Ltd grew its position in shares of Joint by 40.3% during the 3rd quarter. R Squared Ltd now owns 14,910 shares of the company’s stock worth $110,000 after buying an additional 4,284 shares during the period. Strs Ohio lifted its holdings in Joint by 17,300.0% in the first quarter. Strs Ohio now owns 17,400 shares of the company’s stock valued at $154,000 after buying an additional 17,300 shares during the period. Grandeur Peak Global Advisors LLC acquired a new position in Joint in the second quarter valued at approximately $19,059,000. Susquehanna International Group LLP lifted its holdings in Joint by 161.3% in the second quarter. Susquehanna International Group LLP now owns 43,138 shares of the company’s stock valued at $379,000 after buying an additional 26,626 shares during the period. Finally, Squarepoint Ops LLC boosted its stake in Joint by 35.5% in the second quarter. Squarepoint Ops LLC now owns 105,467 shares of the company’s stock valued at $926,000 after acquiring an additional 27,633 shares during the last quarter. Institutional investors and hedge funds own 76.88% of the company’s stock.

Joint Company Profile

The Joint Corp. (NASDAQ: JYNT) is a healthcare services company that operates The Joint Chiropractic, a network of chiropractic clinics in the United States. The company focuses on providing routine chiropractic care intended to support musculoskeletal health, mobility and general wellness.

The Joint Chiropractic clinics offer services such as chiropractic adjustments and related wellness care. The business model is designed to provide convenient, accessible care through walk-in visits, membership plans and prepaid packages, with an emphasis on transparent pricing and extended operating hours.